Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial

• Egile Nagusiak: Byung Jin Kim MD, PhD (Egilea), Kwang Soo Cha MD, PhD (Egilea), Wook Hyun Cho MD, PhD (Egilea), Eung Ju Kim MD, PhD (Egilea), Seung-Hyuk Choi MD, PhD (Egilea), Moo Hyun Kim MD, PhD (Egilea), Sang-Hyun Kim MD, PhD (Egilea), Jun-Bean Park MD, PhD (Egilea), Seong-Mi Park MD, PhD (Egilea), Il Suk Sohn MD, PhD (Egilea), Kyu Hyung Ryu MD, PhD (Egilea), In-Ho Chae MD, PhD (Egilea)
• Formatua: Liburua
• Argitaratua: SAGE Publishing, 2023-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction This study evaluated the efficacy and safety of a single-pill triple-combination of olmesartan/amlodipine/rosuvastatin (Olme/Amlo/Rosu) in comparison with a single-pill dual-combination of olmesartan/amlodipine (Olme/Amlo) in hypertensive patients with low-to-moderate cardiovascular ris...